Showing results (21-30 of 46) with videos related to
Sort By:
Pageof 5
European Journal of Pharmacology|December 23, 2017
Inhibition of activated factor X by rivaroxaban attenuates neointima formation after wire-mediated vascular injuryTomoya Hara, Daiju Fukuda, Kimie Tanaka, et al.Journal of Atherosclerosis and Thrombosis|February 27, 2020
Biodegradable Extremely-Small-Diameter Vascular Graft Made of Silk Fibroin can be Implanted in MiceKimie Tanaka, Daiju Fukuda, Yasutomi Higashikuni, et al.Hypertension Research : Official Journal of the Japanese Society of Hypertension|March 6, 2009
A new constitutively active mutant of AMP-activated protein kinase inhibits anoxia-induced apoptosis of vascular endothelial cellDaisuke Nagata, Arihiro Kiyosue, Masao Takahashi, et al.Biochemical and Biophysical Research Communications|July 10, 2012
Src kinase-mediates androgen receptor-dependent non-genomic activation of signaling cascade leading to endothelial nitric oxide synthaseJing Yu, Masahiro Akishita, Masato Eto, et al.Atherosclerosis|November 26, 2013
HMGB1 plays a critical role in vascular inflammation and lesion formation via toll-like receptor 9Yoichiro Hirata, Hirotsugu Kurobe, Mayuko Higashida, et al.Journal of Bioscience and Bioengineering|March 13, 2013
Genetic manipulations restored the growth fitness of reduced-genome Escherichia coliYasutaka Hirokawa, Hiroaki Kawano, Kimie Tanaka-Masuda, et al.Vascular Pharmacology|March 29, 2017
Teneligliptin, a dipeptidyl peptidase-4 inhibitor, attenuated pro-inflammatory phenotype of perivascular adipose tissue and inhibited atherogenesis in normoglycemic apolipoprotein-E-deficient miceHotimah Masdan Salim, Daiju Fukuda, Yasutomi Higashikuni, et al.Vascular Pharmacology|August 17, 2015
Dipeptidyl peptidase-4 inhibitor, linagliptin, ameliorates endothelial dysfunction and atherogenesis in normoglycemic apolipoprotein-E deficient miceHotimah Masdan Salim, Daiju Fukuda, Yasutomi Higashikuni, et al.Respiratory Research|July 7, 2019
Pleural thickening on screening chest X-rays: a single institutional studyAkira Saito, Yukichika Hakamata, Yukiko Yamada, et al.International Heart Journal|November 19, 2019
Vildagliptin, a DPP-4 Inhibitor, Attenuates Endothelial Dysfunction and Atherogenesis in Nondiabetic Apolipoprotein E-Deficient MiceKunduziayi Aini, Daiju Fukuda, Kimie Tanaka, et al.Pageof 5